China revising GMPs

China is expected to enact a new version of its good manufacturing practices to ensure the quality and safety of national medicines. Future production will need to follow the revised GMP standards, says China Financial Daily.

The State Food and Drug Administration says it will focus on the new standards, especially for essential medicines--those required for basic healthcare needs and that are available to the public at all times and in adequate amounts. These drugs are included in a list published for the first time and expected to be updated annually, according to China Knowledge.

To meet the new standards, some facilities and manufacturing processes may require re-inspection.

- here's the Financial Daily report
- read the China Knowledge item

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.